hotspot -WSS

hotspot

author：knowledge 2025-09-30 01:03:15 - browse：26429

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Activists slam private health insurers over coverage restrictions
Next article： CDC wastewater surveillance dashboard to track bird flu hotspots

leisure time

WSS

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Astellas still sees hope in its gene therapy after four deaths

Making AI in medicine accessible to smaller, and rural hospitals

Use wet bulb globe temperature, not heat index, to protect workers

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Study: AI not yet building 'n

focus

hotspot

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Bird flu outbreak in cows is latest avian flu curveball

In Memoriam: Notable people who died in 2023

CRISPR pioneers react to Casgevy, first gene

Walensky prepares to leave CDC — and Congress — behind

CRISPR pioneers react to Casgevy, first gene

Medical leaders decry Supreme Court decision on affirmative action

CDC wastewater surveillance dashboard to track bird flu hotspots

After affirmative action ruling, medical educators look to 'holistic review'

Astellas still sees hope in its gene therapy after four deaths

hotspot

H5N1 bird flu: what we're starting to learn about infection in cows

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

How to improve immunocompromised access to mAb treatments

FDA's Woodcock to retire early next year

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Use wet bulb globe temperature, not heat index, to protect workers

Wikipedia

focus

leisure time

focus